Despite off-label use of naltrexone by some patients with fibromyalgia in clinical practice, data from a randomized trial showed no pain relief advantage with the drug over placebo.
It's important to ask about sleep and provide targeted interventions to improve sleep and quality of life in women with breast cancer, researchers say.
A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.
Sleep disorders in people with epilepsy are linked to a significantly increased risk for sudden unexplained death in epilepsy and all-cause mortality, new research shows.